0000905718-19-000975.txt : 20191203
0000905718-19-000975.hdr.sgml : 20191203
20191203163949
ACCESSION NUMBER: 0000905718-19-000975
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191129
FILED AS OF DATE: 20191203
DATE AS OF CHANGE: 20191203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sinclair Andrew
CENTRAL INDEX KEY: 0001762451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 191266224
MAIL ADDRESS:
STREET 1: C/O SOLENO THERAPEUTICS INC.
STREET 2: 1235 RADIO ROAD, SUITE 110
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
sierraonco_fm4nov2019.xml
X0306
4
2019-11-29
0
0001290149
Sierra Oncology, Inc.
SRRA
0001762451
Sinclair Andrew
C/O SIERRA ONCOLOGY, INC.
2150-885 WEST GEORGIA STREET
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
1
0
0
0
Stock Option (right to buy)
0.3467
2019-11-29
4
A
0
60000
0
A
2029-11-29
Common Stock $.001 par value
60000
60000
D
The option award was made in accordance with the terms of Sierra Oncology, Inc.'s 2015 Equity Incentive Plan (the "2015 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 29, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2015 Plan.
/s/ John Heard, as attorney-in-fact
2019-12-03